Phase 3Completed
A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)
A Randomized, Double-Blind, Placebo-Controlled,4-Period, Crossover Study to Evaluate the Effects of Ezetimibe and Simvastatin, Coadministered and Alone, on Intestinal Absorption of Cholesterol
- Sponsor
- Organon and Co (Industry)
- Enrolment
- 40 enrolled
- Conditions
- Cholesterol
- Interventions
- ezetimibe; Comparator: Placebo (unspecified); simvastatin
- Ages
- adults
- Registry
- NCT00652301
Full record on ClinicalTrials.gov
From the registry
To determine the effect of ezetimibe and simvastatin given together, and ezetimibe and simvastatin given alone on intestinal cholesterol absorption.
Primary outcomes
- reduced intestinal cholesterol absorption with ezetimibe + simvastatin vs simvastatin alone.
History
Last registry update
Registered
Primary completion
Started